Kynam Capital Management’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
Other funds holding CRBU
Kynam Capital Management's CRBU Position: Q3 2026 in Review
Kynam Capital Management held its Caribou Biosciences (CRBU) position steady in Q3 2026 at 2,503,302 shares worth $3.18M. The position accounts for 0.18% of the portfolio, ranked #31.
Kynam Capital Management first reported a position in CRBU in Q3 2023 and has held it in 13 quarters since. The position peaked at $7.15M in Q3 2025. 144 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.
- Kynam Capital Management held 2,503,302 shares of Caribou Biosciences worth $3.18M as of Q3 2026.
- Kynam Capital Management left its Caribou Biosciences share count unchanged in Q3 2026.
- Caribou Biosciences made up 0.18% of Kynam Capital Management's portfolio in Q3 2026, its #31 holding.
- Kynam Capital Management first reported a position in Caribou Biosciences in Q3 2023 and has held it in 13 quarters since.
- Kynam Capital Management's Caribou Biosciences position peaked at $7.15M in Q3 2025.
- 144 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.
Based on Kynam Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.